Could a common supplement help liver patients in intensive care?
NCT ID NCT07642076
First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times
Summary
This study looks at whether adding L-carnitine, a natural substance, to standard care can improve outcomes for critically ill adults with liver disease in the ICU. About 58 participants with conditions like liver failure or severe infections will be enrolled. Researchers will track key lab tests such as kidney and liver function to see if L-carnitine helps.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FULMINANT HEPATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National liver institute
RECRUITINGMenoufia, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can everyday drugs shield the liver from Cirrhosis's worst threats?
- Melatonin may ease sleep and brain fog in liver disease — a trial puts it to the test
- Can tracking hospital care for liver patients reduce repeat admissions?
- Could a fecal transplant stop dangerous brain fog after liver surgery?
- New study aims to uncover hidden brain complications in liver patients
- New blood thinner trial aims to prevent rebleeding in liver patients